INTRODUCTION
Programed cell death plays an important role in the genesis of cancer[1-5]. Certain cancer genes can regulate apoptosis. Recently, several proteins that are structurally related to Bcl-2, an inhibitor of apoptosis, have been identified[6-11]. Therefore, novel strategies and agents that target specific molecular pathways, as well as triggering a process of cell death, are being evaluated in the treatment of several neoplasms. The homologous Bcl-2 and Bcl-x1 proteins can extend cell survival by suppressing apoptosis[12,13], whereas the proapoptotic proteins (e.g. Bax, Bak, Bik) act as dominant cell death inducers when overexpressed[14,15]. C-myc not only can promote cell growth, but also induce apoptosis. Many studies have shown that oncogene plays an important role in the growth, progression and metastasis of solid tumors. Recently, several oncogene factors have been identified. Primary liver cancer remains one of the most common malignancies worldwide, with an annual incidence of approximately 1 million cases[16,17]. It bears the character of portal venous invasion, so metastases are often presented when the cancer is discovered. We use immunohisto-chemical method to detect the protein expression o f Bcl-2, Bax, c-myc and use TdT-mediated dUTP nick end labeling (TUNEL) method to detect the apoptosis index. The purpose of our study was to evaluate the function of these proteins and their relationship with the clinical characteristics of hepatoma.
MATERIALS AND METHODS
Clinical meterial
Twenty-two resected hepatoma specimens in our hospital from 1994 to 1998 were studied. All the specimens were confirmed by pathology. Twenty-seven were men, and 5 women, average age 50.26 years. No patient had received chemotherapy or radiation therapy before surgery. All the specimens together with some paracance rous tissues were fixed in 100 mL/L formaldehyde solution and embedded in paraffin. Five μm thick sections were cut and mounted on glass slides.
Immunohistochemical determination and in situ hybridization detection
Immunohistochemical determination of Bcl-2, Bax and c-myc Immunohistochemical studies were performed using ABC method. The antibodies of Bcl-2, Bax and c-myc were bought from Boshide Biotechnology, Inc (Wuhan). Immunohist-ochemical assay was performed as described by the manufacturer. Immunohistochemical studies were performed using the streptoavidinbiotin method. Sections were dewaxed in xylene, taken through ethanol, and then incubated with 3 mL/L hydrogen peroxide in methanol for 30 min to block endogenous peroxidase activity. Sections were then washed in phosphate-buffered saline and incubated in 100 mL/L normal goat serum for 20 min to reduce nonspecific antibody binding. Specimens were then incubated with a 1:50 dilution of a primary antibody overnight at 4 °C, followed by three washes with PBS. Sections were then incubated with biotinylated goat antirabbit immunoglobulin G at a dilution of 1:100 for 30 min followed by 3 washes slides were then treated with streptoavidin-peroxidase reagent for 30 min at a dilution of 1:100 and were washed with PBS 3 times. Finally, slides were incubated in PBS containing diaminobenzidine and 10 mL/L hydrogen peroxide for 10 min, counterstained with methyl green, and mounted. Normal rabbit immunoglobulin-G was substituted for primary antibody as the negative control. Slides were interpreted for antigen expression by two investigators without knowledge of the corresponding clinicopathologic data. Ten optical fields, about 500-1000 cells were counted in each slide under the high power (× 400) microscopy. Results presented as -, indicated 25% slightly positively stained cells; +, 25%-50% positive cells; ++, 50%-75% positive cells; +++, > 75% positive cells.
In site hybridization dectetion
Apoptosis was further confirmed by the TdT-mediated DUTP nick end labeling (TUN EL) method using a detection kit from Boshide Biotechnology, INC (Wuhan).
Sections were dewaxed in Xylene, taken through ethanol, and then incubated with 30 mL/L hydrogen peroxide in methanol for 30 min, washed with PBS, incubated in dialysate solution for 2 min on ice, and incubated with TUNEL reaction mixture at 37 °C for 30 min. Samples were washed with PBS, incubated with converter PO D at 37 °C for 1 h and stained with 3,3’-diaminobenzidine tetrahydrochloride. A negative control using all reagents except terminal transferase was performed in parallel. The nucleus of positive cells was stained brown as detected under light microscopy. Ten optical fields, about 500-1000 cells were counted in each slide under the high power (× 400) microscopy. The apoptosis index is the percentage of positive cells in 1000 cells.
Statistical analysis
Statistical significence was determined by using χ2 test or Student’s t test.
RESULTS
The protein expressions of Bcl-2, Bax, c-myc and apoptosis
The rate of Bcl-2 protein positive expression in human hepatocellular carcinoma was 22.73% and it was 18.18% in paracancerous tissues. No difference was seen as compared with each other (P > 0.05). The rate of Bax positive expression was 45.45% in carcinoma tissue and 77.27% in paracancerous tissues (P < 0.01). The rate of c-myc protein expression was 81.82% in carcinoma tissues and 72.73% in paracancerous tissues (P > 0.05). The apoptosis index in hepatocellular carcinoma was 9.55% and was lower than that in paracancerous tissues (P < 0.01).
The relationship between the protein expressions of Bcl-2, Bax and apoptosis index in cancerous tissues and paracancerous tissues
The apoptosis index of Bcl-2 positive group was higher than that of Bcl-2 negative group, but no difference was found between them (P > 0.05); The apoptosis index of Bax positive group was significent higher than that of Bax negative group (P < 0.01) (Table 1).
Table 1.
Case | Apoptosis index % | |
Cancerous tissues | ||
Bcl-2 negative | 17 | 9.12 ± 5.37 |
Bcl-2 positive | 5 | 11.00 ± 5.48 |
Bax negative | 12 | 5.83 ± 1.95 |
Bax positive | 10 | 14.00 ± 4.59b |
Paracancerous tissues | ||
Bcl-2 negative | 18 | 16.39 ± 5.89 |
Bcl-2 positive | 4 | 12.50 ± 5.00 |
Bax negative | 5 | 10.00 ± 3.54 |
Bax positive | 17 | 17.35 ± 5.62b |
P < 0.01 vs compared with Bax negative group.
Relationship between protein expressions of Bcl-2, Bax and protein expression of c-myc in cancerous tissues
In the carcinoma tissues, the expression of c-myc was not related to the expression of Bcl-2 and Bax (Table 2).
Table 2.
c-myc positive | c-myc negative | |
Bcl-2 positive | 3 | 1 |
Bcl-2 negative | 15 | 3 |
Bax positive | 14 | 3 |
Bax negative | 4 | 1 |
DISCUSSION
Apoptosis, a normal cellular process that provides the orderly existence and death of cells in a programmed fashion, may be positively or negatively modulated by several external or internal factors[18-22]. Modern molecular biology investigations have indicated that proliferative inhibition of some neoplasm cells is related to apoptosis induction regulated by the oncogene expression of these cells[23-26]. Recently, regulating apoptosis gene is divided into two groups, existence gene and death gene. Living gene includes improving cell proliferation gene, c-myc and improving cell existence gene, Bcl-2[27-29]. Death gene includes supressing cell proliferation gene i.e. p53 and promoting cell death gene, i.e. Bax[30,31]. It is generally considered that Bcl-2 is an important gene for cell survival, the Bcl-2 gene can inhibit the apoptosis by blocking the last tunnel of apoptotic signal transmitted system[32-37], C-myc is a kind of effective protein of the karyomitosis signal, which can trigger and regulate the transcription of the genes related with proliferation[38]. Some recent study showed that Bcl-2 and Bax play important roles in regulating apoptosis in prostate cancer, mammary cancer and gastric carcinoma[39-41]. But there has been no report on the relationship between regulating apoptosis gene and apoptosis index in human hepatocellular carcinoma.
We detected the protein expression of Bcl-2, Bax and c-myc in hepatocellular carcinoma and paracancerous tissues using immunohistochemical stain. The rate of Bcl-2 protein positive expression in human hepatocellular carcinoma was 22.73 %, and 18.18% in paracancerous tissues. No statistical difference was seen between them (P > 0.05). The result was similar to that of Guo et al[42]. The rate of Bax protein positive expression in hepatocellular carcinoma was 45.45%, and 77.27% in paracancerous tissues. We have found that Bcl-2 and Bax play a crucial role in the genesis of hepatoma. The higher expression of Bcl-2 and the lower expression of Bax supressed apoptosis. These broke the balance between cell proliferation and apoptosis, and resulted in carcinogenesis. Bcl-2 protein blocks apoptosis by binding to and suppressing the action of Bax, a positiver egulator of cell death. The expression of c-myc was higher in the carcinoma tissue than that in paracancerous, but no difference was seen as compared with each other. The result was similar to the report of Yang[43]. The c-myc proto-oncogene, usually implicated in cell transformation, differentiation and cell cycle progression, also has a central role in some forms of apoptos is[44,45]. These opposite roles of c-myc in cell growth and death require other gene products to dictate the outcome of c-myc expression on a cell. We thought that the higher expression of Bcl-2 could not effect cell proliferation, the higher expression of c-myc could improve cell proliferation. The paracancerous tissues may be in the precancer state. But the mechanism of regulating cell apoptosis is intact. The balance of cell proliferation and death was not broken, cell was still in normal state. The paracancerous tissues could become cancer following the enhancing of cell proliferation and the imbalance in regulating apoptosis. Bissonnette RP found that Chinese hamster ovary cell apoptosed due to the proliferation of c-myc gene, but it would be suppressed by Bcl-2 gene[35], and cell would be in a balanced state of proliferation and apoptosis resulting from the appropriate expression of c-myc gene. The balance would be broken by some factors. A ‘two signal’ model emerges, in which c-myc can provide the first signal, leading either to apoptosis or proliferation, and certain growth factors may provide a second signal, to inhibit apoptosis and allow c-myc to drive cells into the cell cycle. Bcl-2 may substitute for the putative signal, as suggested by the abilities of Bcl-2 to delay apoptosis after growth-factor withdrawal and to cooperate with c-myc in transforming cells[46]. In our study, no relation ship was seen between the expressions of c-myc and Bcl-2 or Bax. We propose that c-myc activation affords the advantage of proliferation is essential for carcinogenesis, because the proliferative and apoptosis functions of c-myc are tightly coupled, it is impossible to select only for one without the other. In our study, the number of cases was insufficient to reflect the relationship.
Now, there are a lot of methods to detect apoptosis. But TdT-mediated dUTP nick end labeling method is the most accurate one[47]. It could find the DNA broken in the early stage and accurate localization, so it is most accurate to reflect the status of apoptosis. Using this method, the apoptosis index of paracancerous tissue was 15.68%, which was higher than that of cancer tissues, 9.55%. There was no difference of apoptosis index between the positive and negative expression of Bcl-2. There was significant difference between the apoptosis index in Bax positive and negative group. We thought the balance of the expression of Bcl-2 and Bax may decide whether the cell is alive or dead. The isodipolymer with Bax and Bcl-2 could decide the protein molecules of active Bcl -2 or not. Bcl-2 could have different effects on inducing or inhibiting apoptosis. So isodipolymer Bcl-2/Bax is more accurate in reflecting the status of apoptosis. There were significant differences between the apoptosis index in cancer tissues and paracancerous tissues. It is valuable to study whether apoptosis index could become an index in judging canceration or not.
In conclusion, our study demonstrated that apoptosis plays an important role in the genesis of hepatoma, Bcl-2/Bax could reflect accurately the status of apoptosis. Apoptosis index was the most accurate index to reflect apoptosis, and may become an index for judging carcinogenesis. It is also valuable to study whether c-myc is affected by Bcl-2 and Bax expression.
Footnotes
Supported by Heilongjiang Natural Science Foundation, No.D9846
Edited by You DY Proofread by Zhu LH and Ma JY
References
- 1.Sun BH, Zhao XP, Wang BJ, Yang DL, Hao LJ. FADD and TRADD expression and apoptosis in primary hepatocellular carcinoma. World J Gastroenterol. 2000;6:223–227. doi: 10.3748/wjg.v6.i2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Liang YR, Zheng SY, Shen YQ, Wu XY, Huang ZZ. Relation-ship between expression of apoptosis related antigens in hepa-tocellular carcinoma and in situ end labeling. World J Gastroentero. 1998;4:99. [Google Scholar]
- 3.Zhuang XQ, Yuan SZ, Wang XH, Lai RQ, Luo ZQ. Oncoprotein expression and inhibition of apoptosis during colorectal tumorigenesis. China Natl J New Gastroenterol. 1996;2:3–5. [Google Scholar]
- 4.Huang PL, Zhu SN, Lu SL, Dai ZS, Jin YL. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol. 2000;6:295–297. doi: 10.3748/wjg.v6.i2.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sun ZX, Ma QW, Zhao TD, Wei YL, Wang GS, Li JS. Apoptosis induced by norcantharidin in human tumor cells. World J Gastroenterol. 2000;6:263–265. doi: 10.3748/wjg.v6.i2.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wang LD, Zhou Q, Wei JP, Yang WC, Zhao X, Wang LX, Zou JX, Gao SS, Li YX, Yang CS. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl- 2 and c myc in esophageal carcinogenesis studied with a high risk population in northern China. World J Gastroentero. 1998;4:287–293. doi: 10.3748/wjg.v4.i4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dai J, Yu SX, Qi XL, Bo AH, Xu YL, Guo ZY. Expression of bcl 2 and c-myc protein in gastric carcinoma and precancerous lesions. World J Gastroentero. 1998;4(Suppl 2):84–85. [Google Scholar]
- 8.Cao GD, Wang SW, Wu SS, Li HF, Zhang WG. Retrovirus medi-ated antisense RNA to bcl-2 alter the biological behavior of stomach carcinoma MGC 803 cell lines. World J Gastroentero. 1998;4(Suppl 2):45–48. [Google Scholar]
- 9.Wang XW, Xie H. Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells. World J Gastroenterol. 1998;4:540–543. doi: 10.3748/wjg.v4.i6.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Liu HF, Liu WW, Fang DC, Men RP. Expression of bcl-2 protein in gastric carcinoma and its significance. World J Gastroenterol. 1998;4:228–230. doi: 10.3748/wjg.v4.i3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bellamy COC, Malcomson RDG, Harrison DJ, Wyllie AH. Cell death in health and disease: the biology and regulation of apoptosis. Sem Cancer. 1972;26:239–257. doi: 10.1006/scbi.1995.0002. [DOI] [PubMed] [Google Scholar]
- 12.Hawkins CJ, Vaux DL. Analysis of the role of bcl-2 in apoptosis. Immunol Rev. 1994;142:127–139. doi: 10.1111/j.1600-065x.1994.tb00886.x. [DOI] [PubMed] [Google Scholar]
- 13.Reed JC. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt. 1996;97:72–100. [PubMed] [Google Scholar]
- 14.Liu HF, Liu WW, Fang DC, Men RP. Expression and significance of proapoptotic gene Bax in gastric carcinoma. World J Gastroenterol. 1999;5:15–17. doi: 10.3748/wjg.v5.i1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang XM, Wang X, Li J, Evers BM. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines. Ann Surg. 1998;227:922–931. doi: 10.1097/00000658-199806000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5–27. doi: 10.3322/canjclin.47.1.5. [DOI] [PubMed] [Google Scholar]
- 17.Tsai SL, Liaw YF. Etiology and pathogenesis of hepatocellular carcinoma. Dig Surg. 1995;12:7–15. [Google Scholar]
- 18.Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Liang YR, Zheng SY, Shen YQ, Wu XY, Huang ZZ. Relationship between expression of apoptosis related antigens in hepatocellular carcinoma and in situ end labeling. Huaren Xiaohua Zazhi. 1998;6:236–239. [Google Scholar]
- 20.Li J, Wang WL, Liu B. Angiogenesis and apoptosis in human hepatocellular carcinoma. Huaren Xiaohua Zazhi. 1998;6:1057–1060. [Google Scholar]
- 21.Guo WJ, Yu EX, Zheng SG, Shen ZZ, Luo JM, Wu GH, Xia SA. Study on the apoptosis and cell cycle arrest in human liver cancer SMMC7721 cells induced by Jianpiliqi herbs. Shijie Huaren Xiaohua Zazhi. 2000;8:52–55. [Google Scholar]
- 22.Chen HY, Liu WH, Qin SK. Induction of arsenic trioxide on apoptosis of hepatocarcinoma cell lines. Shijie Huaren Xiaohua Zazhi. 2000;8:532–535. [Google Scholar]
- 23.Kong XP, Zou QY, Li RB, Zheng PL, Yang LP, Jin SW. Apoptosis of neoplasm cell lines induced by hepatic peptides extracted from sucking porcine hepat ocytes. World J Gastroentero. 1999;5:435–439. doi: 10.3748/wjg.v5.i5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Tu SP, Jiang SH, Tan JH, Jiang XH, Qiao MM, Zhang YP, Wu YL, Wu YX. Proliferation inhibition and apoptosis induction by arsenic trioxide on gastric cancer cell SGC 7901. Shijie Huaren Xiaohua Zazhi. 1999;7:18–21. [Google Scholar]
- 25.Shen YF, Zhuang H, Shen JW, Chen SB. Cell apoptosis and neoplasms. Shijie Huaren Xiaohua Zazhi. 1999;7:267–268. [Google Scholar]
- 26.Liang YR, Wang CF, Zhou JH, Peng XZ. Apoptosis of hepato-cyte and preca ncerous lesion of hepatocellular carcinoma. Huaren Xiaohua Zazhi. 1998;6(Suppl 7):160–162. [Google Scholar]
- 27.Chen RF, Zou SQ, Qian JQ. Apoptosis and expression of bcl-2 gene in gallbladder neoplasms. Huaren Xiaohua Zazhi. 1998;6:680–682. [Google Scholar]
- 28.Peng XM, Peng WW, Chen Q, Yao JL. Apoptosis, Bcl-2 and P53 proteine xpressions in tissues from hepatocellular carcinoma. Huaren Xiaohua Zazhi. 1998;6:834–836. [Google Scholar]
- 29.Wang JM, Zou Q, Zou SQ. The role of bcl-2 gene in apoptosis of liver in rat with obstructive jaundice. Shijie Huaren Xiaohua Zazhi. 1999;7:1035–1037. [Google Scholar]
- 30.Cheng J. Apoptosis and disease. Beijing: Bei Jing Medical University; 1997. pp. 40–45. [Google Scholar]
- 31.Qiao Q, Wu JS, Zhang J, Ma QJ, Lai DN. Expression and significance of apoptosis related gene bcl-2, bax in human large intestine adenocarcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:936–938. [Google Scholar]
- 32.Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 1995;55:4438–4445. [PubMed] [Google Scholar]
- 33.Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334–336. doi: 10.1038/348334a0. [DOI] [PubMed] [Google Scholar]
- 34.Mandal M, Wu X, Kumar R. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Carcinogenesis. 1997;18:229–232. doi: 10.1093/carcin/18.1.229. [DOI] [PubMed] [Google Scholar]
- 35.Boyd JM, Gallo GJ, Elangovan B. Bik. A novel death inducing protein, sharesa distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival promoting proteins. Oncogene. 1995;11:1921–1928. [PubMed] [Google Scholar]
- 36.Bellamy CO, Malcomson RD, Harrison DJ, Wyllie AH. Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol. 1995;6:3–16. doi: 10.1006/scbi.1995.0002. [DOI] [PubMed] [Google Scholar]
- 37.Hawkins CJ, Vaux DL. Analysis of the role of bcl-2 in apoptosis. Immunol Rev. 1994;142:127–139. doi: 10.1111/j.1600-065x.1994.tb00886.x. [DOI] [PubMed] [Google Scholar]
- 38.He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma. World J Gastroenterol. 1999;5:408–416. doi: 10.3748/wjg.v5.i5.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Xue XC, Fang GE, Hua JD. Gastric cancer and apoptosis. Shijie Huaren Xiaohua Zazhi. 1999;7:359–361. [Google Scholar]
- 40.Liu HF, Liu WW, Fang DC, Yang SM, Wang RQ. Bax gene expression and its relationship with apoptosis in human gastric carci-noma and precancerous lesions. Shijie Huaren Xiaohua Zazhi. 2000;8:665–668. [Google Scholar]
- 41.Li XL, Hao YR, Zou JX, Yang JH, Geng JH. Relationship between C-myc and Bcl-2 alterations and biological behavior and apoptosis in gastric cancer. Xin Xiaohuabingxue Zazhi. 1997;5:773–774. [Google Scholar]
- 42.Guo LL, Cao CA, Wang YS. The study of the expression of Bcl-2 and Bax in hepatocelluler carcinoma. Xin Xiaohuabingxue Zazhi. 1997;5:655–656. [Google Scholar]
- 43.Yang S, Wang M, You W. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization] Zhonghua Zhongliu Zazhi. 1995;17:415–417. [PubMed] [Google Scholar]
- 44.Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 1992;359:552–554. doi: 10.1038/359552a0. [DOI] [PubMed] [Google Scholar]
- 45.Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990;348:331–333. doi: 10.1038/348331a0. [DOI] [PubMed] [Google Scholar]
- 46.Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 1992;359:554–556. doi: 10.1038/359554a0. [DOI] [PubMed] [Google Scholar]
- 47.Li J, Wang WL, Wang WY, Liu B, Wang BY. Apoptosis in human hepatocellular carcinoma by terminal deoxynucleotidyl transferase mediate dUTP-FITC nick end labeling. Huaren Xiaohua Zazhi. 1998;6:491–494. [Google Scholar]